加拿大安大略省参加综合和标准药物使用治疗方案的孕妇的新生儿结局。

IF 2.8 3区 医学 Q1 NURSING Birth-Issues in Perinatal Care Pub Date : 2023-11-20 DOI:10.1111/birt.12784
Karen Milligan PhD, Lesley A. Tarasoff PhD, Erica R. Rodrigues MA, Tomisin Iwajomo MPH, Tara Gomes PhD, Claire de Oliveira PhD, Hilary K. Brown PhD, Karen A. Urbanoski PhD
{"title":"加拿大安大略省参加综合和标准药物使用治疗方案的孕妇的新生儿结局。","authors":"Karen Milligan PhD,&nbsp;Lesley A. Tarasoff PhD,&nbsp;Erica R. Rodrigues MA,&nbsp;Tomisin Iwajomo MPH,&nbsp;Tara Gomes PhD,&nbsp;Claire de Oliveira PhD,&nbsp;Hilary K. Brown PhD,&nbsp;Karen A. Urbanoski PhD","doi":"10.1111/birt.12784","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Substance use in pregnancy raises concern given its potential teratogenic effects. Given the unique needs of parenting people and the potential impact for developing children, specialized substance use treatment programs are increasingly being implemented for this population. Substance use treatment is associated with more positive neonatal outcomes compared with no treatment, however treatment models vary limiting our understanding of key treatment components/modelsFew studies have explored the influence of treatment model type (i.e., integrated treatments designed for pregnant clients compared with standard treatment models) and no studies have examined the influence of treatment model on neonatal outcomes using Canadian data.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>We conducted a population-based cohort study of clients who were pregnant when initiating integrated (<i>n</i> = 564) and standard (<i>n</i> = 320) substance use treatment programs in Ontario, Canada.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Neonatal outcomes did not significantly differ by treatment type (integrated or standard), with rates of adverse neonatal outcomes higher than published rates for the general population, despite receipt of adequate levels of prenatal care. While this suggests no significant impact of treatment, it is notable that as a group, clients engaged in integrated treatment presented with more risk factors for adverse neonatal outcomes than those in standard treatment. While we controlled for these risks in our analyses, this may have obscured their influence in relation to treatment type.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Findings underscore the need for more nuanced research that considers the influence of client factors in interaction with treatment type. Pregnant clients engaged in any form of substance use treatment are at higher risk of having children who experience adverse neonatal outcomes. This underscores the urgent need for further investment in services and research to support maternal and neonatal health before and during pregnancy, as well as long-term service models that support women and children beyond the perinatal and early childhood periods.</p>\n </section>\n </div>","PeriodicalId":55350,"journal":{"name":"Birth-Issues in Perinatal Care","volume":"51 2","pages":"284-294"},"PeriodicalIF":2.8000,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/birt.12784","citationCount":"0","resultStr":"{\"title\":\"Neonatal outcomes of pregnant women attending integrated and standard substance use treatment programs in Ontario, Canada\",\"authors\":\"Karen Milligan PhD,&nbsp;Lesley A. Tarasoff PhD,&nbsp;Erica R. Rodrigues MA,&nbsp;Tomisin Iwajomo MPH,&nbsp;Tara Gomes PhD,&nbsp;Claire de Oliveira PhD,&nbsp;Hilary K. Brown PhD,&nbsp;Karen A. Urbanoski PhD\",\"doi\":\"10.1111/birt.12784\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Substance use in pregnancy raises concern given its potential teratogenic effects. Given the unique needs of parenting people and the potential impact for developing children, specialized substance use treatment programs are increasingly being implemented for this population. Substance use treatment is associated with more positive neonatal outcomes compared with no treatment, however treatment models vary limiting our understanding of key treatment components/modelsFew studies have explored the influence of treatment model type (i.e., integrated treatments designed for pregnant clients compared with standard treatment models) and no studies have examined the influence of treatment model on neonatal outcomes using Canadian data.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Method</h3>\\n \\n <p>We conducted a population-based cohort study of clients who were pregnant when initiating integrated (<i>n</i> = 564) and standard (<i>n</i> = 320) substance use treatment programs in Ontario, Canada.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Neonatal outcomes did not significantly differ by treatment type (integrated or standard), with rates of adverse neonatal outcomes higher than published rates for the general population, despite receipt of adequate levels of prenatal care. While this suggests no significant impact of treatment, it is notable that as a group, clients engaged in integrated treatment presented with more risk factors for adverse neonatal outcomes than those in standard treatment. While we controlled for these risks in our analyses, this may have obscured their influence in relation to treatment type.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Findings underscore the need for more nuanced research that considers the influence of client factors in interaction with treatment type. Pregnant clients engaged in any form of substance use treatment are at higher risk of having children who experience adverse neonatal outcomes. This underscores the urgent need for further investment in services and research to support maternal and neonatal health before and during pregnancy, as well as long-term service models that support women and children beyond the perinatal and early childhood periods.</p>\\n </section>\\n </div>\",\"PeriodicalId\":55350,\"journal\":{\"name\":\"Birth-Issues in Perinatal Care\",\"volume\":\"51 2\",\"pages\":\"284-294\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2023-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/birt.12784\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Birth-Issues in Perinatal Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/birt.12784\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NURSING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Birth-Issues in Perinatal Care","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/birt.12784","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0

摘要

背景:药物使用在怀孕引起关注,因为其潜在的致畸作用。鉴于为人父母者的独特需求和对发育中的儿童的潜在影响,专门的药物使用治疗方案正越来越多地为这一人群实施。与不治疗相比,药物使用治疗与更积极的新生儿结局相关,然而治疗模式的不同限制了我们对关键治疗成分/模式的理解。很少有研究探索治疗模式类型的影响(即,与标准治疗模式相比,为怀孕客户设计的综合治疗),也没有研究使用加拿大的数据检查治疗模式对新生儿结局的影响。方法:我们在加拿大安大略省进行了一项基于人群的队列研究,研究对象是在开始综合(n = 564)和标准(n = 320)药物使用治疗方案时怀孕的客户。结果:新生儿结局在治疗类型(综合或标准)上没有显著差异,尽管接受了足够的产前护理,但新生儿不良结局的发生率高于公布的一般人群的发生率。虽然这表明治疗没有显著的影响,但值得注意的是,作为一个群体,参与综合治疗的客户比接受标准治疗的客户出现了更多的新生儿不良结局的危险因素。虽然我们在分析中控制了这些风险,但这可能掩盖了它们与治疗类型相关的影响。结论:研究结果强调需要进行更细致的研究,考虑患者因素与治疗类型相互作用的影响。从事任何形式的药物使用治疗的孕妇客户,其子女经历不良新生儿结局的风险较高。这突出表明迫切需要进一步投资于服务和研究,以支持孕前和怀孕期间的孕产妇和新生儿保健,以及支持围产期和幼儿期以外的妇女和儿童的长期服务模式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Neonatal outcomes of pregnant women attending integrated and standard substance use treatment programs in Ontario, Canada

Background

Substance use in pregnancy raises concern given its potential teratogenic effects. Given the unique needs of parenting people and the potential impact for developing children, specialized substance use treatment programs are increasingly being implemented for this population. Substance use treatment is associated with more positive neonatal outcomes compared with no treatment, however treatment models vary limiting our understanding of key treatment components/modelsFew studies have explored the influence of treatment model type (i.e., integrated treatments designed for pregnant clients compared with standard treatment models) and no studies have examined the influence of treatment model on neonatal outcomes using Canadian data.

Method

We conducted a population-based cohort study of clients who were pregnant when initiating integrated (n = 564) and standard (n = 320) substance use treatment programs in Ontario, Canada.

Results

Neonatal outcomes did not significantly differ by treatment type (integrated or standard), with rates of adverse neonatal outcomes higher than published rates for the general population, despite receipt of adequate levels of prenatal care. While this suggests no significant impact of treatment, it is notable that as a group, clients engaged in integrated treatment presented with more risk factors for adverse neonatal outcomes than those in standard treatment. While we controlled for these risks in our analyses, this may have obscured their influence in relation to treatment type.

Conclusion

Findings underscore the need for more nuanced research that considers the influence of client factors in interaction with treatment type. Pregnant clients engaged in any form of substance use treatment are at higher risk of having children who experience adverse neonatal outcomes. This underscores the urgent need for further investment in services and research to support maternal and neonatal health before and during pregnancy, as well as long-term service models that support women and children beyond the perinatal and early childhood periods.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Birth-Issues in Perinatal Care
Birth-Issues in Perinatal Care 医学-妇产科学
CiteScore
4.10
自引率
4.00%
发文量
90
审稿时长
>12 weeks
期刊介绍: Birth: Issues in Perinatal Care is a multidisciplinary, refereed journal devoted to issues and practices in the care of childbearing women, infants, and families. It is written by and for professionals in maternal and neonatal health, nurses, midwives, physicians, public health workers, doulas, social scientists, childbirth educators, lactation counselors, epidemiologists, and other health caregivers and policymakers in perinatal care.
期刊最新文献
Issue Information A History of Cesarean Birth as a Risk Factor for Postpartum Hemorrhage Even After Successful Planned Vaginal Birth. Pregnant Women's Care Needs During Early Labor-A Scoping Review. Sociodemographic and Health-Related Risk Factors Associated With Planned and Emergency Cesarean Births in Mexico. Validating the Quality Maternal and Newborn Care Framework Index: A Global Tool for Quality-of-Care Evaluations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1